Form 8-K InMed Pharmaceuticals For: Oct 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
InMed Pharmaceuticals appoints Neil Klompas to board of directors
October 14, 2025 6:07 AM EDTInMed Pharmaceuticals Inc. (NASDAQ: INM) appointed Neil Klompas as a director to its board, effective October 9, 2025. The pharmaceutical company also expanded its board size to five members.
The board made the appointment on October 7, 2025, according to a company statement. Klompas may be assigned to board... More
